HomeCompareTREP vs MRK

TREP vs MRK: Dividend Comparison 2026

TREP yields 9546.54% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TREP wins by $34906749767769464.00M in total portfolio value
10 years
TREP
TREP
● Live price
9546.54%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34906749767769464.00M
Annual income
$34,201,986,692,176,153,000,000.00
Full TREP calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — TREP vs MRK

📍 TREP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTREPMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TREP + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TREP pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TREP
Annual income on $10K today (after 15% tax)
$811,455.85/yr
After 10yr DRIP, annual income (after tax)
$29,071,688,688,349,730,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, TREP beats the other by $29,071,688,688,349,730,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TREP + MRK for your $10,000?

TREP: 50%MRK: 50%
100% MRK50/50100% TREP
Portfolio after 10yr
$17453374883884732.00M
Annual income
$17,100,993,346,088,076,000,000.00/yr
Blended yield
97.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TREP
No analyst data
Altman Z
1.3
Piotroski
2/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TREP buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTREPMRK
Forward yield9546.54%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$34906749767769464.00M$57.7K
Annual income after 10y$34,201,986,692,176,153,000,000.00$10,113.78
Total dividends collected$34859815971837028.00M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TREP vs MRK ($10,000, DRIP)

YearTREP PortfolioTREP Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$965,354$954,653.94$11,213$373.04+$954.1KTREP
2$87,161,801$86,128,872.75$12,667$512.06+$87.15MTREP
3$7,361,090,624$7,267,827,495.97$14,439$708.14+$7361.08MTREP
4$581,512,896,570$573,636,529,602.67$16,640$988.16+$581512.88MTREP
5$42,973,856,463,962$42,351,637,664,632.44$19,432$1,394.07+$42973856.44MTREP
6$2,971,019,328,365,836$2,925,037,301,949,396.50$23,057$1,992.90+$2971019328.34MTREP
7$192,173,322,544,371,200$188,994,331,863,019,700.00$27,889$2,894.79+$192173322544.34MTREP
8$11,630,531,136,421,894,000$11,424,905,681,299,415,000.00$34,518$4,286.29+$11630531136421.86MTREP
9$658,657,079,993,747,100,000$646,212,411,677,775,800,000.00$43,912$6,494.35+$658657079993747.13MTREP
10$34,906,749,767,769,462,000,000$34,201,986,692,176,153,000,000.00$57,714$10,113.78+$34906749767769464.00MTREP

TREP vs MRK: Complete Analysis 2026

TREPStock

True solutions, today and tomorrow: Trucept Inc. helps organizations focus on growing their business. With a dedicated suite of powerful tools and services designed to put business owners in charge of running their businesses and increasing efficiency, Trucept tackles a variety of important administrative needs and provides a host of value-added advantages. For more information, call 858-798-1620 or visit https://truceptservices.com/.

Full TREP Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this TREP vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TREP vs SCHDTREP vs JEPITREP vs OTREP vs KOTREP vs MAINTREP vs JNJTREP vs ABBVTREP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.